Drug Strategies
- Assets
- $462.7k
- Revenue
- $182.1k
- Investments
- $0.0
- Employees
- 1
- Location
- Washington, DC
- Founding
- 10/1993
- Data as of
- 06/2022
- EIN
- 52-1837390
Organization Overview
Drug Strategies is located in Washington, DC. The organization was established in 1993. According to its NTEE Classification (W20) the organization is classified as: Government & Public Administration, under the broad grouping of Public & Societal Benefit and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Drug Strategies is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2022, Drug Strategies generated $182.1k in total revenue. The organization has seen a slow decline revenue. Over the past 8 years, revenues have fallen by an average of (1.4%) each year. All expenses for the organization totaled $284.1k during the year ending 06/2022. As we would expect to see with falling revenues, expenses have declined by (0.9%) per year over the past 8 years. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
DRUG STRATEGIES PROMOTES MORE EFFECTIVE APPROACHES TO THE NATION'S DRUG PROBLEMS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
DRUG STRATEGIES' PRIMARY FOCUS IS ON RESPONDING TO THE CURRENT OVERDOSE EPIDEMIC IN THE US, DRIVEN LARGELY BY THE OPIOID FENTANYL. IN 2021, MORE THAN 100,000 DRUG OVERDOSE DEATHS WERE REPORTED, AND THE NUMBERS CONTINUE TO CLIMB. GREATER EFFORTS AT PREVENTION AND TREATMENT ARE URGENTLY NEEDED.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Marian Wright Edelman Director | Trustee | 1 | $0 |
Louise Bryson Director | Trustee | 1 | $0 |
Morris Panner Director | Trustee | 1 | $0 |
Michael Kantor Director | Trustee | 1 | $0 |
Ambassador James R Jones Board Chair | OfficerTrustee | 1 | $0 |
Marni Vliet Director | Trustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Total Revenue from Contributions, Gifts, Grants & Similar | $100,000 |
| Investment income | $56,644 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $25,396 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $182,093 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $105,666 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $3,094 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $1,286 |
| Fees for services: Accounting | $4,818 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $15,957 |
| Advertising and promotion | $1,676 |
| Office expenses | $33,727 |
| Information technology | $5,488 |
| Royalties | $0 |
| Occupancy | $31,200 |
| Travel | $43,151 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $1,010 |
| Insurance | $0 |
| All other expenses | $0 |
| Total functional expenses | $284,100 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $110,961 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $2,216 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Investments—publicly traded securities | $327,751 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $462,658 |
| Accounts payable and accrued expenses | $32,587 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $32,587 |
| Net assets without donor restrictions | $430,071 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Total liabilities and net assets/fund balances | $430,071 |